-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Addressing Inflammaging As Secondary Prevention in Clonal Hematopoiesis

Scientific Workshop on Clonal Hematopoiesis
Program: Scientific Workshops
Session: Clinical Trial Approaches in Clonal Hematopoiesis
Friday, December 6, 2024, 3:50 PM-4:55 PM

Amit Verma, MD

Albert Einstein College of Medicine, Bronx, NY; Montefiore Einstein Comprehensive Cancer Center, Blood Cancer Institute, Department of Oncology, Montefiore Health System, Inc., Bronx, NY

Disclosures: Verma: Stelexis: Current equity holder in private company, Honoraria; Curis: Research Funding; Prelude: Research Funding; Aurigene: Consultancy, Honoraria; BMS: Research Funding; Halia: Research Funding.

See more of: Clinical Trial Approaches in Clonal Hematopoiesis
See more of: Scientific Workshop on Clonal Hematopoiesis
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation >>